Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Deferred Taxes (2023)

Perspective Therapeutics' Deferred Taxes history spans 1 years, with the latest figure at $7.8 million for Q4 2023.

  • For Q4 2023, Deferred Taxes changed N/A year-over-year to $7.8 million; the TTM value through Sep 2024 reached $7.8 million, up 174.75%, while the annual FY2023 figure was -$2.7 million, N/A changed from the prior year.
  • Deferred Taxes for Q4 2023 was $7.8 million at Perspective Therapeutics, up from -$10.5 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $7.8 million in Q4 2023 and bottomed at -$10.5 million in Q1 2023.